Drug Database
CO

collagenase (Plaquase / Nucleolysin / lipolysin)

✓ Approved

Johnson & Johnson Services, Inc. · therapeutic agent

What is collagenase?

collagenase is a therapeutic agent developed by Johnson & Johnson Services, Inc.. It is approved for therapeutic indications via injectable (others) or topical.

Drug Profile

Brand NamesPlaquase, Nucleolysin, lipolysin
CompanyJohnson & Johnson Services, Inc.
RouteInjectable (Others), Topical
StatusApproved
Sources: ClinicalTrials.gov, Johnson & Johnson Services, Inc.

Therapeutic Indications

collagenase is developed for 10 unique indications across 7 therapeutic areas.

Therapeutic AreaConditionPhase
Skin and subcutaneous tissue disordersDecubitus ulcer✓ Approved
Injury, poisoning and procedural complicationsThermal burn✓ Approved
Skin and subcutaneous tissue disordersDiabetic foot✓ Approved
Musculoskeletal and connective tissue disordersDupuytren's contracture✓ Approved
Eye disordersGlaucoma✓ Approved

+5 more indications available with a free account

Sign up free to view all indications →

Related Research Articles

Unable to load articles right now.

Ask about collagenase